User is impressed with 3-month progress using Hims oral finasteride, minoxidil, and biotin. Encouragement to view hair loss treatment as a long-term strategy.
The conversation discusses hair regrowth using topical RU58841 and Minoxidil. Users suggest adding finasteride or dutasteride for better long-term results.
PP405 is anticipated as a future treatment for dormant hair follicles, but its effectiveness and safety are uncertain. Current treatments include oral minoxidil and microneedling, with some avoiding finasteride due to side effects.
Dutasteride and finasteride are not effectively stopping hair loss for some users, despite long-term use. Some are considering or using RU58841, pyrilutamide, and other treatments like microneedling, while also managing seborrheic dermatitis with diet and topical solutions.
The conversation discusses hair loss treatments, specifically the use of topical minoxidil and derma-stamping, with suggestions to add finasteride or dutasteride for better long-term results. Ketoconazole shampoo is also considered for scalp health.
Stopping Minoxidil after 3 weeks is unlikely to cause long-term effects, and it's fine to see how you respond to Finasteride. Finasteride targets DHT, the main cause of hair loss, and using both treatments together often yields the best results.
Tretinoin and microneedling both enhance hair growth through different mechanisms, with microneedling being considered safe for long-term use. Optimal microneedling needle length varies, but 0.8 mm is suggested for hair growth, and a Dermastamp is recommended to avoid skin damage.
PP405 significantly improves hair density, outperforming finasteride, with 31% of users seeing over 20% improvement in four weeks. Concerns exist about its availability, cost, and long-term effects.
The conversation discusses hair loss treatments, specifically the use of minoxidil and dermarolling, with suggestions to add finasteride for better long-term results. The user shares progress after two months of using topical minoxidil twice daily and dermarolling once a week, while considering starting finasteride.
The conversation discusses hair loss treatments, focusing on the use of Minoxidil, finasteride, and triamcinolone. Concerns are raised about high concentrations of Minoxidil and the long-term use of corticosteroids.
A user is using Minoxidil, finasteride, saw palmetto, and Minimalist RCP serum to address hair thinning, with some success but concerns about the long-term benefits of Minimalist. They plan to continue Minoxidil and finasteride for another year before considering a hair transplant.
Finasteride significantly improved hair density and reduced hair loss for the user over two years, with plans to switch to dutasteride for long-term benefits. The user experienced no shedding or side effects and obtained finasteride through a private prescription in the UK.
Cetirizine 10mg daily reduced hair shedding by 50% and lessened scalp itchiness. The user is considering long-term use for scalp inflammation and hair loss.
Finasteride showed faster hair regrowth within 3 months, while dutasteride took 8 months but resulted in twice the regrowth. Overall, finasteride had quicker results, but dutasteride had more significant long-term regrowth.
Finasteride and Dutasteride are effective treatments for hair loss, with Dutasteride being superior based on long-term data. Side effects are minimal, and concerns should not deter treatment.
PP405 may help with hair regrowth, especially when combined with minoxidil and finasteride, but its long-term effectiveness is unclear. Phase 3 trials are expected to begin soon, with results in a few years.
Celebrities may use Dutasteride for hair loss, but Finasteride is more commonly used due to its extensive research and long-term safety. Dutasteride is considered more effective but is often used off-label or as a secondary option.
Finasteride and minoxidil are effective for hair loss, with many users finding them manageable as part of a daily routine. Costs can be reduced by purchasing generic versions, and while some users express concerns about long-term use, most agree the benefits outweigh the inconvenience.
Hair follicles often go dormant rather than die, and treatments like minoxidil can help revive them. Scalp health and stimulation, such as massages and using products like sulphur soap, are also important for hair regrowth.
People are hopeful for a permanent hair loss solution by the 2030s, considering options like hair cloning and treatments like pp405. Synthetic hair transplants have been attempted but are not effective long-term.
Veradermics' oral minoxidil shows promise for hair regrowth, with some users reporting significant improvements, while Pelage's PP405 results are less convincing and lack transparency. There is skepticism about both treatments' long-term effectiveness and potential side effects.
Pelage Pharmaceuticals raised $120M for their hair loss treatment, PP405, showing strong investor confidence despite limited data. There is skepticism about its efficacy and long-term effects compared to treatments like GT20029.
Oral minoxidil significantly increases hair growth, including facial hair, in a short period. Some users suggest combining it with finasteride for better long-term results, despite potential side effects.
PP405 is a new hair loss treatment that may outperform minoxidil and finasteride by growing thick hair in bald areas within four weeks. Its release is expected around 2028, but concerns about its long-term efficacy and cost remain.
The user shared their successful hair regrowth journey using minoxidil 5% twice daily and weekly microneedling. Other users suggested adding finasteride to maintain gains long-term.
Minoxidil initially showed great results for hair loss but plateaued, leading to the addition of finasteride and dutasteride. The user is considering restarting minoxidil and is concerned about its long-term effects on skin.
A 33-year-old is considering using Minoxidil and Dutasteride for hair loss but is hesitant due to concerns about long-term commitment and side effects. They are advised to consider starting with topical treatments to assess their response.
PP405 shows potential for hair growth, with 31% of advanced balding men experiencing over 20% increase in hair density in 8 weeks. However, skepticism persists due to selective data presentation and lack of long-term results, with comparisons to treatments like minoxidil and finasteride.
PP405 shows promise as a hair loss treatment, with 31% experiencing increased hair density in a short trial. It may complement treatments like finasteride and minoxidil, but long-term effectiveness and safety need confirmation.
A treatment showed a 20% hair density increase in weeks, with nearly a third of participants experiencing significant results, while questions remain about its long-term efficacy and effectiveness across different scalp areas. There is interest in combining it with finasteride and minoxidil for potentially better outcomes.